P.P. Koopmans

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV

Brookie M. Best, P.P. Koopmans, Scott Letendre et al. · Journal of Antimicrobial Chemotherapy · 2010 · 91 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Zidovudine and Interferon-  Combination Therapy versus Zidovudine Monotherapy in Subjects with Symptomatic Human Immunodeficiency Virus Type 1 Infection

P. H. J. Frissen, Chris H.H. ten Napel, H Weigel et al. · The Journal of Infectious Diseases · 1994 · 34 citations

Pharmacy, Infectious Diseases, Pharmacology +17

Adherence over 48 Weeks in An Antiretroviral Clinical Trial: Variable within Patients, Affected by Toxicities and Independently Predictive of Virological Response

Pythia T. Nieuwkerk, Elisabeth H. Gisolf, Mirjam A. G. Sprangers et al. · Antiviral Therapy · 2001 · 33 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D‐deficient HIV‐1‐infected patients

CJP Van Den Bout‐van den Beukel, M Van Den Bos, Ad R. Hermus et al. · HIV Medicine · 2008 · 31 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study

Helen Kovari, Caroline Sabin, Bruno Ledergerber et al. · Open Forum Infectious Diseases · 2016 · 29 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17